Propofol cardioplegia: A single-center, placebo-controlled, randomized controlled trial.

[1]  G. Angelini,et al.  Liberal or restrictive transfusion after cardiac surgery. , 2015, The New England journal of medicine.

[2]  G. Angelini,et al.  The Effects of Propofol Cardioplegia on Blood and Myocardial Biomarkers of Stress and Injury in Patients With Isolated Coronary Artery Bypass Grafting or Aortic Valve Replacement Using Cardiopulmonary Bypass: Protocol for a Single-Center Randomized Controlled Trial , 2014, JMIR research protocols.

[3]  Jie Gu,et al.  Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats. , 2013, Microvascular research.

[4]  S. Kjeldsen,et al.  Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. , 2012, American heart journal.

[5]  N. King,et al.  Propofol improves recovery of the isolated working hypertrophic heart from ischaemia–reperfusion , 2012, Pflügers Archiv - European Journal of Physiology.

[6]  G. Heusch,et al.  Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol – a clinical trial , 2012, Acta anaesthesiologica Scandinavica.

[7]  M. Irwin,et al.  Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients. , 2011, Clinical science.

[8]  W. Luo,et al.  Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model. , 2011, Life sciences.

[9]  A. Halestrap.  A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. , 2010, Biochemical Society transactions.

[10]  D. Chambers,et al.  Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion. , 2010, Pharmacology & therapeutics.

[11]  P. Pasdois,et al.  The role of the mitochondrial permeability transition pore in heart disease. , 2009, Biochimica et biophysica acta.

[12]  C. Royse,et al.  Functional comparison of anaesthetic agents during myocardial ischaemia-reperfusion using pressure-volume loops. , 2009, British journal of anaesthesia.

[13]  J. Januzzi,et al.  Prospective, Comprehensive Assessment of Cardiac Troponin T Testing After Coronary Artery Bypass Graft Surgery , 2009, Circulation.

[14]  A. Halestrap.  Mitochondria and reperfusion injury of the heart—A holey death but not beyond salvation , 2009, Journal of bioenergetics and biomembranes.

[15]  N. Kanaya,et al.  Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3β , 2008, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[16]  E. Murphy,et al.  Ion transport and energetics during cell death and protection. , 2008, Physiology.

[17]  A. Namiki,et al.  Propofol attenuates ischaemia‐reperfusion injury in the rat heart in vivo , 2008, European journal of anaesthesiology.

[18]  G. Angelini,et al.  Inflammatory response and cardioprotection during open‐heart surgery: the importance of anaesthetics , 2008, British journal of pharmacology.

[19]  D. Ansley,et al.  Large-Dose Propofol During Cardiopulmonary Bypass Decreases Biochemical Markers of Myocardial Injury in Coronary Surgery Patients: A Comparison with Isoflurane , 2006, Anesthesia and analgesia.

[20]  J. Bovill.  Intravenous Anesthesia for the Patient with Left Ventricular Dysfunction , 2006, Seminars in cardiothoracic and vascular anesthesia.

[21]  M. Okusa,et al.  Acute kidney injury associated with cardiac surgery. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[22]  G. Angelini,et al.  Propofol Is Cardioprotective in a Clinically Relevant Model of Normothermic Blood Cardioplegic Arrest and Cardiopulmonary Bypass , 2005, Experimental biology and medicine.

[23]  J. Scholz,et al.  Sevoflurane but Not Propofol Preserves Myocardial Function During Minimally Invasive Direct Coronary Artery Bypass Surgery , 2005, Anesthesia and analgesia.

[24]  N. Dhalla,et al.  Role of oxidative stress in cardiovascular diseases , 2000, Journal of hypertension.

[25]  G. Angelini,et al.  Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. , 2000, Cardiovascular research.

[26]  M. Caputo,et al.  The end of the cold era: from intermittent cold to intermittent warm blood cardioplegia. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[27]  J. Soler‐Soler,et al.  Sodium/hydrogen exchanger inhibition reduces myocardial reperfusion edema after normothermic cardioplegia. , 1998, The Journal of thoracic and cardiovascular surgery.

[28]  J. Soler‐Soler,et al.  Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition. , 1995, Cardiovascular research.

[29]  D. Garcia-Dorado,et al.  Myocardial oedema: a preventable cause of reperfusion injury? , 1993, Cardiovascular research.

[30]  G. Buckberg,et al.  Myocardial protection: an overview. , 1993, Seminars in thoracic and cardiovascular surgery.

[31]  G. Heusch,et al.  Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. , 2014, The Journal of thoracic and cardiovascular surgery.

[32]  C. Hoppel,et al.  Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. , 2007, American journal of physiology. Cell physiology.

[33]  D. Godin,et al.  Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation. , 2003, Canadian journal of physiology and pharmacology.

[34]  M. Caputo,et al.  Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia , 2002 .

[35]  A. Halestrap,et al.  Mitochondria: a target for myocardial protection. , 2001, Pharmacology & therapeutics.